Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports
<p dir="ltr">The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We reported two cases of patients...
Saved in:
| Main Author: | Alaaeldin Abdelmajid (12535542) (author) |
|---|---|
| Other Authors: | Wala Osman (17269054) (author), Huda Musa (17269057) (author), Hisham Elhiday (17269060) (author), Waqar Munir (14506265) (author), Muna A. Al.Maslamani (17269063) (author), Eman Zeyad Elmekaty (17269066) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melatonin-induced symptomatic bradycardia in an otherwise healthy male: a case report
by: Asim Alawad (19489015)
Published: (2024) -
Fatal Coronavirus Disease 2019-associated Pulmonary Aspergillosis; A Report of Two Cases and Review of the Literature
by: Shiema Abdalla (9538596)
Published: (2020) -
Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach
by: Junaed Younus Khan (16870110)
Published: (2020) -
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
by: Sara Al-Khawaga (4792761)
Published: (2020) -
Is there a diurnal variation of COVID-19 patients warranting presentation to the health centre? A chronobiological observational cross-sectional study
by: Mohamed Romdhani (9606357)
Published: (2022)